WHAT YOU NEED TO KNOW
  • Roughly 180,000 veterans might qualify under preliminary screening criteria, but reaching a four digit patient count during the first year could prove difficult.
  • The VA selected 10 initial facilities but has not publicly released the full list or requested dedicated fiscal 2027 implementation funding.
  • A September inspector general report found that 58% of reporting VA facilities identified severe psychologist shortages.
  • Andrew Gradison promised Congress a staffing plan and the list of initial facilities within 30 days.

The Department of Veterans Affairs estimates that roughly 180,000 veterans might qualify for emerging psychedelic assisted mental health treatments under preliminary screening criteria. Yet a senior official has warned that reaching even a four digit patient count during the first year could be challenging.

That potential chasm between eligibility and actual treatment capacity came under scrutiny Wednesday during a House Veterans’ Affairs subcommittee hearing. Lawmakers questioned whether the VA has enough trained clinicians, facilities and funding to treat veterans with post traumatic stress disorder and severe depression.

“If we save one veteran’s life next year from these treatments, it’s worth it,” Andrew Gradison, a senior adviser to the Veterans Health Administration, told lawmakers.

The VA has selected 10 facilities to support its initial rollout, with locations designated for clinical implementation and clinician training. Officials have not publicly released the complete list, adding another unanswered question to a rollout already facing close congressional attention.

Warning: Account balances and purchasing power no longer tell the same story. Know in 2 minutes if your retirement is working for you.

The department’s fiscal 2027 budget contained no dedicated funding request for implementing the treatments. VA officials nevertheless maintained that existing resources would be enough to begin the effort.

Rep. Maggie Goodlander, D-N.H., pressed Gradison about how the department would choose which veterans receive treatment first if demand greatly exceeds available appointments.

“Who goes first, and who decides?” Goodlander asked. “Is there going to be a role for priority, or does it depend on whether you live near one of the 10 sites?”

Gradison said those decisions would be directed by medical ethics, clinical eligibility and patient safety. The treatments would initially be administered by the department’s most experienced clinicians.

FREE Gun Law Map: Laws Don't Pause During Social Unrest

Should Election Day be a federal holiday?

By completing the poll, you agree to receive emails from BoredTrashPanda.com, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement.

The 180,000 estimate comes from screening criteria used in existing research and does not represent confirmed eligibility for an approved treatment. Actual eligibility will depend on which therapies, if any, receive Food and Drug Administration approval and what restrictions accompany that approval.

Gradison previously discussed the challenge of reaching a four digit patient count at an October healthcare forum. His assessment was not a formal capacity projection, and he did not establish a firm treatment capacity for the first year during Wednesday’s hearing.

VA officials said approximately 2.1 million veterans receiving VA healthcare have diagnoses involving PTSD, major depressive disorder or treatment resistant depression. As of September, the agency was conducting 21 active psychedelic treatment studies, including research involving MDMA and psilocybin.

The department’s research protocols require preparation, supervised dosing sessions lasting six to eight hours and follow up treatment. That lengthy process places substantial demands on the clinicians and facilities responsible for each patient.

Lawmakers questioned whether the VA could sustain that workload while facing existing staffing pressures. A September VA inspector general report found that 58% of reporting VA facilities identified severe shortages of psychologists, while federal workforce data showed declines among VA physicians, psychologists and social workers.

Dr. Ilse Wiechers, a senior Veterans Health Administration official, said the VA continues recruiting mental health professionals. The department is also evaluating staffing requirements at the facilities selected for the initial phase.

Officials acknowledged that geographic access would remain limited during the beginning of the rollout. The VA plans to expand beyond the initial facilities as additional clinicians receive training, while also developing standards for referrals to community providers.

Regulatory obstacles will remain even if the FDA approves a therapy. Psychedelic compounds currently classified as Schedule I controlled substances would require additional federal action and potentially state regulatory action before they could enter routine clinical use.

Rep. Morgan Luttrell, R-Texas, a longtime advocate for psychedelic treatments for veterans, urged officials to move carefully while warning about the consequences of a failed implementation. “If you mess up this much, this goes away forever,” Luttrell said.

Gradison agreed to provide Congress with a staffing plan within 30 days, including the number of clinicians required, where those employees would come from and the projected costs. He also committed to giving lawmakers the list of 10 facilities selected for the initial rollout.

The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of BoredTrashPanda.com. Contact us for guidelines on submitting your own commentary.